RTOG-0436
|
RTOG
|
A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel; Cisplatin; and Radiation for Patients with Esophageal Cancer who are Treated without Surgery
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
RTOG-0521
|
RTOG
|
A Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT vs. AS and 3DCRT/IMRT followed by Chemotherapy with Docetaxel and Prednisone for Localized; High-Risk Prostate Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
RTOG-0522
|
RTOG
|
A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin Versus Concurrent Accelerated Radiation; Cisplatin and Cetuximab (C225) [Followed by Surgery for Selected Patients] For Stage III and IV Head and Neck Carcinomas<br>
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
RTOG-0525
|
RTOG
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
RTOG-0534
|
RTOG
|
A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
RTOG-0617
|
RTOG
|
A Randomized Phase III Comparison of Standard-Dose (60 Gy) versus High-Dose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab (IND #103444) in Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
RTOG-0724
|
RTOG
|
Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
RTOG-0815
|
RTOG
|
A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
RTOG-0825
|
RTOG
|
Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide plus Bevacizumab versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
RTOG-0848
|
RTOG
|
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma <br>
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|